Invention Grant
- Patent Title: Antisense modulation of PTP1B expression
-
Application No.: US14685228Application Date: 2015-04-13
-
Publication No.: US09404113B2Publication Date: 2016-08-02
- Inventor: Sanjay Bhanot , Susan M. Freier
- Applicant: Ioins Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: Ionis Pharmaceuticals, Inc. Patent Dept.
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/02 ; C07H21/04 ; C12N15/113 ; A61K31/7088

Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of PTP1B mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate metabolic disease, for example, diabetes, or a symptom thereof.
Public/Granted literature
- US20150315596A1 ANTISENSE MODULATION OF PTP1B EXPRESSION Public/Granted day:2015-11-05
Information query